Wednesday, May 13, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

A Month of Uncertainty

Filling a prescription has become a circus of folly.

Laurie Engels by Laurie Engels
January 20, 2024
in Uncertainty & Complexity
0
A Month of Uncertainty

Tbel Abuseridze

Uncertainty is an inherent aspect of the human experience. We understand that elements like weather, accidents, and acts of God are beyond our control. However, imagine if the uncertainty you faced in your life was manipulated by political forces. I believe most individuals would find this unsettling. In 2024, as a chronic pain patient, uncertainty will undeniably play a significant role in your life. Every month, you embark on a roller coaster ride, uncertain of whether you will have access to your necessary prescription medications.

Intractable pain is a rare and debilitating condition that has significant impacts on the cardiovascular, endocrine, and autoimmune systems. Unlike simple chronic pain or low back pain, intractable pain is constant and never subsides. There are several underlying conditions that often accompany intractable pain, including Adhesive Arachnoiditis, Stroke, Traumatic Brain Injury, and CRPS. Many patients with intractable pain transitioned from chronic pain over time, with the development of a systemic autoimmune response that affects the nervous system. In order to protect these patients and their treating physicians from anti-opioid movements, states like Minnesota, Colorado, and California have implemented legislation. These patients often face shortened lifespans or tragically resort to suicide when their pain is not effectively managed. Currently, the most commonly available FDA-approved medications for severe pain belong to the opioid class of drugs.

Consider a scenario where an individual is faced with a debilitating condition that causes unbearable pain, only to be informed that their essential medications will no longer be accessible in order to benefit society as a whole. This raises concerns about one’s own well-being and significance. It is important to emphasize that there has been no misuse or distribution of these medications. Furthermore, this person’s medical condition bears no responsibility for the increasing rates of overdose related to illicitly manufactured fentanyl. Unfortunately, facts and the right to receive prescribed treatment have seemingly become irrelevant within certain anti-opioid circles.

When you find yourself questioning every month whether or not you’ll be able to get your necessary medication, it can be disheartening. Seeing your friends in the chronic pain community facing the same struggle only adds to that frustration. The first hurdle you have to overcome is your doctor. What many people don’t realize is that doctors are being influenced by various external factors. Regulators may visit them in person, their malpractice carrier may send a letter, or they may even receive a call from the state medical board. These tactics, while not overtly aggressive, are designed to pressure doctors into reducing the number and dosage of prescriptions they write. Unfortunately, this reduction is often the only metric considered important. Patient outcomes seem to take a backseat in these instances.

When it comes to filling your prescription, there are a couple of hoops you’ll need to jump through at the pharmacy. The first hurdle is the pharmacist themselves. It’s important for them to know and trust you and your healthcare provider. Unfortunately, if you’re faced with a float pharmacist who doesn’t know you at all, it may be difficult for them to have that level of trust. Filling your prescription carries risks for their license and livelihood, so they may be hesitant.

The second hoop involves recent history and medication availability. Since 2015, the DEA has significantly reduced production quotas for opioid pain medications by over 70%, leading to nationwide shortages. Furthermore, starting in June 2022, the nationwide opioid settlement implemented a secretive system where distributors are forbidden from disclosing quotas to pharmacies.

If a pharmacy exceeds their monthly numbers without knowing the quotas, they risk being cut off from receiving controlled medication shipments completely. This can quickly put them out of business. It’s no wonder this process has become such a complex and challenging situation for everyone involved. It has become a circus of folly.

Living with intractable pain is an extremely challenging and distressing experience. Despite the existence of laws aimed at safeguarding both doctors and patients, the situation seems to be deteriorating rather than improving as time goes on. The consequences are dire: patients continue to endure immense suffering, healthcare professionals themselves are burdened by this crisis, and individuals struggling with addiction tragically lose their lives. It is high time for society to recognize this pressing issue, demand a higher standard of care, and show genuine compassion towards those facing these hardships.

Blessings, Laurie

ShareTweet
Laurie Engels

Laurie Engels

I have lived my life in MN growing up the youngest of five. I graduated high school in 1976 and got my BS in Animal Science at the U of MN. I started graduate school but never finished. I have spent the last 25 years of my life devoted to breeding and showing English Setter dogs. I live by myself in Minneapolis.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The 340B Coalition

    The 340B Coalition

    0 shares
    Share 0 Tweet 0
  • The Rebate That Ate the List Price

    0 shares
    Share 0 Tweet 0
  • The Number Nobody Publishes

    0 shares
    Share 0 Tweet 0
  • How Smart Kitchen Renovations Support Healthy Habits and Wellness

    0 shares
    Share 0 Tweet 0
  • Force of Impact in a Tackle

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy